INOBYS LTD. – Trademark Portfolio
Entity Type: 03
INOBYS LTD. holds 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 10 Nice Classification classes. The owner is based in PLEASANTON, CA.
4747 WILLOW ROAD
PLEASANTON, CA 94588
Showing of trademarks Trademarks
Trademark Classifications
INOBYS LTD.'s trademark portfolio spans 10 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does INOBYS LTD. have?
INOBYS LTD. has 23 U.S. trademarks filed with the USPTO.
What trademark classes does INOBYS LTD. file in?
INOBYS LTD. files trademarks across 10 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages), Class 30 (Staple Foods), Class 29 (Meats & Processed Foods), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is INOBYS LTD.'s trademark registration success rate?
INOBYS LTD. has a 0% trademark registration rate, with 0 out of 23 resolved applications resulting in successful registration. Currently, 0 applications are pending review.